Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. latamerica
  4. vascular structure
Show results for
Products
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Vascular Structure Articles & Analysis

15 news found

Confluent Medical Technologies Announces Grand Opening of Costa Rica Expansion

Confluent Medical Technologies Announces Grand Opening of Costa Rica Expansion

” Confluent supports some of the fastest growing medical device markets such as Interventional Neurovascular, Electrophysiology, Structural Heart, and Peripheral Vascular. As a result of the double-digit growth of these currently served markets, a substantial number of new products are coming into production and will utilize this new facility space ...

ByConfluent Medical Technologies


Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy

Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy

End of study brings Robocath closer to commercializing R-One in China in 2023 149 patients enrolled over six months in four Chinese centers Results of first vascular robotics study on this scale in China will be published in March 2023 Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular ...

ByRobocath


SANUWAVE Health Announces Issuance of Eleven New Patents Bringing the Company`s Total Number of Active Patents and Patent Applications to 150

SANUWAVE Health Announces Issuance of Eleven New Patents Bringing the Company`s Total Number of Active Patents and Patent Applications to 150

(OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of ...

BySanuwave and Sanuwave Health, Inc.


SANUWAVE Health and JV Partner Diversa S.A. Announce Distribution Agreement with Grupo Suprimed

SANUWAVE Health and JV Partner Diversa S.A. Announce Distribution Agreement with Grupo Suprimed

About SANUWAVE Health SANUWAVE Health (OTCQB: SNWV) is focused on the research, development, and commercialization of its patented, Energy First non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. SANUWAVE's end-to-end wound care portfolio of regenerative ...

BySanuwave and Sanuwave Health, Inc.


SANUWAVE Health Announces Patent Activity from March 2021 to March 2022

SANUWAVE Health Announces Patent Activity from March 2021 to March 2022

(SNWV) focuses on the development and commercialization of innovative advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications of shockwave and ultrasound systems in the non-medical field, announced today the patent activity for the past year. ...

BySanuwave and Sanuwave Health, Inc.


SANUWAVE Announces New Board Leadership

SANUWAVE Announces New Board Leadership

” About SANUWAVE SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. SANUWAVE’s end-to-end wound care portfolio of regenerative medicine products and ...

BySanuwave and Sanuwave Health, Inc.


SANUWAVE Business Update

SANUWAVE Business Update

” About SANUWAVE SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. SANUWAVE’s end-to-end wound care portfolio of regenerative medicine products and ...

BySanuwave and Sanuwave Health, Inc.


AI Specialists Manchester Imaging Win UK Innovation Scholars Grant to Develop AI-enhanced Skin Cancer Detection Capability for Michelson Diagnostics’ VivoSight OCT Scanner

AI Specialists Manchester Imaging Win UK Innovation Scholars Grant to Develop AI-enhanced Skin Cancer Detection Capability for Michelson Diagnostics’ VivoSight OCT Scanner

Michelson’s VivoSight Dx OCT scanner is the world’s leading Optical Coherence Tomography (OCT) skin imaging system which can see over 1 mm deep into the skin to produce images of skin structural elements, vascularity and pathology. It has CE mark, FDA 510(k) and TGA clearance for use in Europe, USA and Australia. ...

ByMichelson Diagnostics Ltd. (MDL)


SANUWAVE Health Presents dermaPACE System Treatment Study Results Showing Enhanced Localized Wound Tissue Oxygenation

SANUWAVE Health Presents dermaPACE System Treatment Study Results Showing Enhanced Localized Wound Tissue Oxygenation

(OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for focused, shockwave systems in the non-medical field today presented results from a clinical case series that demonstrated improved wound healing when treated with its ...

BySanuwave and Sanuwave Health, Inc.


SANUWAVE Rebrands to Reflect Evolved Wound Care Solutions

SANUWAVE Rebrands to Reflect Evolved Wound Care Solutions

(OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, today announced its rebranding. The new brand reflects the evolution of SANUWAVE’s solutions addressing the entire wound care pathway through its portfolio of ...

BySanuwave and Sanuwave Health, Inc.


SANUWAVE Health Announces Expansion of Ametus Group Distribution Partnership

SANUWAVE Health Announces Expansion of Ametus Group Distribution Partnership

(OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, announced today that the Company has entered into a non-exclusive sales and marketing agreement with Ametus to market and sell the Company’s portfolio of wound care ...

BySanuwave and Sanuwave Health, Inc.


Michelson Diagnostics teams up with AI Specialists Manchester Imaging to develop Machine Learning Algorithms for VivoSight OCT Skin Imaging System

Michelson Diagnostics teams up with AI Specialists Manchester Imaging to develop Machine Learning Algorithms for VivoSight OCT Skin Imaging System

The VivoSight Dx is the world’s leading Optical Coherence Tomography (OCT) skin imaging system which can see over 1 mm deep into the skin to produce images of skin structural elements, vascularity and pathology. Collaboration on Artificial Intelligence (AI) The collaboration between Michelson Diagnostics and Manchester Imaging will focus on creating ...

ByMichelson Diagnostics Ltd. (MDL)


Imperative Care Announces FDA Clearance of Initial Products

Imperative Care Announces FDA Clearance of Initial Products

” Imperative Care’s first products are neurovascular access catheters designed to enable smooth, consistent navigation deep into blood vessels of the brain, which can be challenging because of the brain’s highly complex and twisted vascular structure. The catheters are designed to enable physicians to navigate to the treatment site with greater ...

ByImperative Care


Colibri Heart Valve Forms a New Entity to Monetize Tissue Processing Technology in Applications Outside of Structural Heart

Colibri Heart Valve Forms a New Entity to Monetize Tissue Processing Technology in Applications Outside of Structural Heart

Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, announces the formation of a new company called Colorado Therapeutics LLC. In conjunction with its formation, Colibri has granted Colorado Therapeutics a license to develop and market innovative and disruptive xenogenic (sourced from different mammalian species) ...

ByColibri Heart Valve LLC


Colibri Heart Valve Forms a New Entity to Monetize Tissue Processing Technology in Applications Outside of Structural Heart

Colibri Heart Valve Forms a New Entity to Monetize Tissue Processing Technology in Applications Outside of Structural Heart

Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, announces the formation of a new company called Colorado Therapeutics LLC. In conjunction with its formation, Colibri has granted Colorado Therapeutics a license to develop and market innovative and disruptive xenogenic (sourced from different mammalian species) ...

ByColibri Heart Valve LLC

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT